Breast coil facilitates MR diagnostic and interventional procedures
The Access Breast Coil appearing for the first time at the RSNA meeting has a multichannel phased-array architecture to enhance image quality of the breast, axillary tissue, and chest wall. The investigational device, which is being shown at the Confirma booth, has multiple receivers to power the phased-array coils, which may reduce MR imaging time, as well as a large field-of-view. It can support unilateral and bilateral imaging.
The Access Breast Coil appearing for the first time at the RSNA meeting has a multichannel phased-array architecture to enhance image quality of the breast, axillary tissue, and chest wall. The investigational device, which is being shown at the Confirma booth, has multiple receivers to power the phased-array coils, which may reduce MR imaging time, as well as a large field-of-view. It can support unilateral and bilateral imaging.
The new coil has been designed with diagnostics, intervention, and ergonomics in mind. As an open coil, it provides access to interventional procedures from cranial-caudal, lateral, and medial directions.
The Access is equipped with elements that stabilize the breast and guide needle positioning. Its interventional components can accommodate all needle gauge sizes and vacuum-assisted biopsy systems. An integrated lighting system illuminates the biopsy field.
To maximize patient comfort, the breast coil has positioning accessories that not only reduce pressure on the sternum but adjust to the patient during breast MR diagnostic studies and interventional procedures. The accessories include a headrest, armrest, and torso pad.
Confirma markets computer-aided detection systems. Its premier product for automatically processing MR breast images, CADstream, is being used clinically by more than 150 centers in the U.S.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
